Shanghai Waker Biotechnology
Latest round
- Series A
Last raised
- Nov 2025
Total raised
- $14M
Investors
- 3
About Shanghai Waker Biotechnology
, dba Waker Bioscience or Shanghai Waker Biotechnology, develops genomic-safety evaluation technologies and analytical tools for the gene-therapy industry. Its LTA-PCR and TES systems form the world’s first validated ISA detection method and have supported multiple FDA and EMA-approved gene-therapy mutation-risk assessments. The company works with gene-therapy developers, biotech firms, and pharmaceutical R&D teams to deliver insertion-mutation risk evaluations, high-accuracy CRISPR/Cas9 off-target profiling, and optimized sgRNA selection services. It offers proprietary genomic-analysis platforms, ISA detection assays, and expert technical support to help customers improve the safety and precision of gene-therapy programs. The company generates revenue through genomic-analysis service fees, specialized assay offerings, and enterprise partnerships for customized gene-therapy safety evaluations.
Who invested in Shanghai Waker Biotechnology
3 investors across 2 rounds
See all investors in Shanghai Waker Biotechnology
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Shanghai Waker Biotechnology
Who invested in Shanghai Waker Biotechnology?
Shanghai Waker Biotechnology has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Shanghai Waker Biotechnology raised?
Shanghai Waker Biotechnology has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Shanghai Waker Biotechnology last raise money?
Shanghai Waker Biotechnology's most recent round on record is a Series A, in Nov 2025.
What does Shanghai Waker Biotechnology do?
, dba Waker Bioscience or Shanghai Waker Biotechnology, develops genomic-safety evaluation technologies and analytical tools for the gene-therapy industry.
Where is Shanghai Waker Biotechnology headquartered?
Shanghai Waker Biotechnology is headquartered in Shanghai, China.
Which VCs invest in companies like Shanghai Waker Biotechnology?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Shanghai Waker Biotechnology's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Shanghai Waker Biotechnology? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.